Core Viewpoint - Guangkang Biochemical experienced a decline of 2.41% in stock price on October 30, with a trading volume of 42.54 million yuan, indicating potential market volatility and investor sentiment concerns [1] Financing Summary - On October 30, Guangkang Biochemical had a financing buy-in amount of 3.42 million yuan and a financing repayment of 3.43 million yuan, resulting in a net financing buy of -3,800 yuan [1] - As of October 30, the total financing and securities lending balance for Guangkang Biochemical was 75.25 million yuan, accounting for 7.12% of its circulating market value, which is above the 60th percentile level over the past year, indicating a relatively high financing balance [1] - The company had no securities lending transactions on October 30, with a securities lending balance of 0.00 yuan, placing it in the 90th percentile level over the past year, suggesting a high level of securities lending activity [1] Company Overview - Guangkang Biochemical, established on October 17, 2003, and listed on June 27, 2023, is located in Tianhe District, Guangzhou, Guangdong Province [2] - The company specializes in the research, production, and sales of pesticide active ingredients, intermediates, and formulations, and is a major supplier of SDHI, trichloromethylthio fungicides, biphenyl hydrazine acaricides, and pyrethroid insecticides in China [2] - The revenue composition of Guangkang Biochemical includes 82.42% from active ingredients, 17.31% from formulations, 0.15% from pesticide intermediates, and 0.12% from other sources [2] Financial Performance - For the period from January to September 2025, Guangkang Biochemical achieved a revenue of 550 million yuan, representing a year-on-year growth of 13.53% [2] - The net profit attributable to shareholders for the same period was 34.84 million yuan, reflecting a significant year-on-year increase of 47.10% [2] Dividend Information - Since its A-share listing, Guangkang Biochemical has distributed a total of 49.95 million yuan in dividends [3]
广康生化10月30日获融资买入342.43万元，融资余额7525.07万元